6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine

C101H90Cl3N30O+ — CID 157131091

IUPAC6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine
SMILESC=C(C)c1nc(-c2cc(Cl)c3c(=O)[nH]ccc3c2)c(-c2ccn(C)n2)nc1N.Cc1ccn(-c2nc(N)c(C3CC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cc1ccn(-c2nc(N)c(C3CCC3)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cc1ccn(-c2nc(N)c(C3CCC3)nc2-c2ccc3ncccc3c2)n1.Nc1nc(-[n+]2ccccc2)c(-c2ccc3ncccc3c2)nc1C1CC1
InChIInChI=1S/C21H20N6.C21H18N5.C20H17ClN6O.C20H17ClN6.C19H18ClN7/c1-13-9-11-27(26-13)21-19(24-18(20(22)25-21)14-4-2-5-14)16-7-8-17-15(12-16)6-3-10-23-17;22-20-18(14-6-7-14)24-19(21(25-20)26-11-2-1-3-12-26)16-8-9-17-15(13-16)5-4-10-23-17;1-10(2)16-19(22)25-18(14-5-7-27(3)26-14)17(24-16)12-8-11-4-6-23-20(28)15(11)13(21)9-12;1-11-6-8-27(26-11)20-18(24-17(12-4-5-12)19(22)25-20)14-9-13-3-2-7-23-16(13)15(21)10-14;1-10-5-6-27(26-10)19-17(23-16(18(21)24-19)11-3-2-4-11)12-7-13-9-22-25-15(13)14(20)8-12/h3,6-12,14H,2,4-5H2,1H3,(H2,22,25);1-5,8-14H,6-7H2,(H2,22,25);4-9H,1H2,2-3H3,(H2,22,25)(H,23,28);2-3,6-10,12H,4-5H2,1H3,(H2,22,25);5-9,11H,2-4H2,1H3,(H2,21,24)(H,22,25)/q;+1;;;
InChIKeyQXFBSAQZOHHOAK-UHFFFAOYSA-N
MW1846.40 g/mol
LogP19.43
Rot. Bonds15

About 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine

6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine (PubChem CID 157131091) has the molecular formula C101H90Cl3N30O+ and a molecular weight of 1846.40 g/mol. Its IUPAC name is 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine.

Molecular Properties

Compound Name6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine
PubChem CID157131091
Molecular FormulaC101H90Cl3N30O+
Molecular Weight1846.40 g/mol
Exact Mass1843.70
IUPAC Name6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine
SMILESC=C(C)c1nc(-c2cc(Cl)c3c(=O)[nH]ccc3c2)c(-c2ccn(C)n2)nc1N.Cc1ccn(-c2nc(N)c(C3CC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cc1ccn(-c2nc(N)c(C3CCC3)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cc1ccn(-c2nc(N)c(C3CCC3)nc2-c2ccc3ncccc3c2)n1.Nc1nc(-[n+]2ccccc2)c(-c2ccc3ncccc3c2)nc1C1CC1
InChIInChI=1S/C21H20N6.C21H18N5.C20H17ClN6O.C20H17ClN6.C19H18ClN7/c1-13-9-11-27(26-13)21-19(24-18(20(22)25-21)14-4-2-5-14)16-7-8-17-15(12-16)6-3-10-23-17;22-20-18(14-6-7-14)24-19(21(25-20)26-11-2-1-3-12-26)16-8-9-17-15(13-16)5-4-10-23-17;1-10(2)16-19(22)25-18(14-5-7-27(3)26-14)17(24-16)12-8-11-4-6-23-20(28)15(11)13(21)9-12;1-11-6-8-27(26-11)20-18(24-17(12-4-5-12)19(22)25-20)14-9-13-3-2-7-23-16(13)15(21)10-14;1-10-5-6-27(26-10)19-17(23-16(18(21)24-19)11-3-2-4-11)12-7-13-9-22-25-15(13)14(20)8-12/h3,6-12,14H,2,4-5H2,1H3,(H2,22,25);1-5,8-14H,6-7H2,(H2,22,25);4-9H,1H2,2-3H3,(H2,22,25)(H,23,28);2-3,6-10,12H,4-5H2,1H3,(H2,22,25);5-9,11H,2-4H2,1H3,(H2,21,24)(H,22,25)/q;+1;;;
InChIKeyQXFBSAQZOHHOAK-UHFFFAOYSA-N
XLogP19.43
TPSA434.37 Ų
H-Bond Donors7
H-Bond Acceptors28
Rotatable Bonds15
Heavy Atoms135
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001846.40
LogP ≤ 519.43
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine?
The IUPAC name of 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine (CID 157131091) is 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine.
What is the SMILES notation for 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine?
The canonical SMILES for 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine is C=C(C)c1nc(-c2cc(Cl)c3c(=O)[nH]ccc3c2)c(-c2ccn(C)n2)nc1N.Cc1ccn(-c2nc(N)c(C3CC3)nc2-c2cc(Cl)c3ncccc3c2)n1.Cc1ccn(-c2nc(N)c(C3CCC3)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cc1ccn(-c2nc(N)c(C3CCC3)nc2-c2ccc3ncccc3c2)n1.Nc1nc(-[n+]2ccccc2)c(-c2ccc3ncccc3c2)nc1C1CC1.
What is the InChIKey of 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine?
The InChIKey is QXFBSAQZOHHOAK-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20N6.C21H18N5.C20H17ClN6O.C20H17ClN6.C19H18ClN7/c1-13-9-11-27(26-13)21-19(24-18(20(22)25-21)14-4-2-5-14)16-7-8-17-15(12-16)6-3-10-23-17;22-20-18(14-6-7-14)24-19(21(25-20)26-11-2-1-3-12-26)16-8-9-17-15(13-16)5-4-10-23-17;1-10(2)16-19(22)25-18(14-5-7-27(3)26-14)17(24-16)12-8-11-4-6-23-20(28)15(11)13(21)9-12;1-11-6-8-27(26-11)20-18(24-17(12-4-5-12)19(22)25-20)14-9-13-3-2-7-23-16(13)15(21)10-14;1-10-5-6-27(26-10)19-17(23-16(18(21)24-19)11-3-2-4-11)12-7-13-9-22-25-15(13)14(20)8-12/h3,6-12,14H,2,4-5H2,1H3,(H2,22,25);1-5,8-14H,6-7H2,(H2,22,25);4-9H,1H2,2-3H3,(H2,22,25)(H,23,28);2-3,6-10,12H,4-5H2,1H3,(H2,22,25);5-9,11H,2-4H2,1H3,(H2,21,24)(H,22,25)/q;+1;;;.
What are the key properties of 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine?
6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine has a molecular weight of 1846.40 g/mol, XLogP of 19.43, 15 rotatable bonds, 7 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[5-amino-3-(1-methylpyrazol-3-yl)-6-prop-1-en-2-ylpyrazin-2-yl]-8-chloro-2H-isoquinolin-1-one;5-(7-chloro-1H-indazol-5-yl)-3-cyclobutyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;5-(8-chloroquinolin-6-yl)-3-cyclopropyl-6-(3-methylpyrazol-1-yl)pyrazin-2-amine;3-cyclobutyl-6-(3-methylpyrazol-1-yl)-5-quinolin-6-ylpyrazin-2-amine;3-cyclopropyl-6-pyridin-1-ium-1-yl-5-quinolin-6-ylpyrazin-2-amine is sourced from PubChem (CID 157131091), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).